Developing affordable cervical cancer screening and treatment for women with HIV
Official title: Project 1
Funded at University of Tx Md Anderson Can Ctr · NIH-10895287 · Data updated 2026-11-12
This study is working to improve how we find and treat cervical cancer in women living with HIV in Brazil and Mozambique, using new and affordable methods, including technology, to make healthcare better for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $406,956 |
| NIH project number | 5U54CA277843-02 |
| Project ID | NIH-10895287 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women living with HIV, particularly those in low- and middle-income countries who are at risk for cervical cancer.
✕Less likely to help
Patients who do not have HIV or are not at risk for cervical cancer may not benefit from this research.
What this research studies
This research aims to create sustainable infrastructure for addressing HIV-associated malignancies, particularly cervical cancer, in women living with HIV in Brazil and Mozambique. The project focuses on developing innovative, low-cost, and technologically feasible methods for screening, diagnosing, and treating cervical cancer. By collaborating with experts in various fields, the research will implement multi-institutional studies to improve healthcare outcomes for women affected by HIV. The approach includes leveraging artificial intelligence and algorithmic analyses to enhance the effectiveness of cancer care.
Why it matters
Potential benefit: If successful, this research could significantly improve cervical cancer outcomes for women living with HIV in low- and middle-income countries.
How similar studies have gone: Previous research has shown success in developing low-cost cancer screening methods in similar populations, indicating a promising avenue for this approach.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Kreitchmann, Regis — University of Tx Md Anderson Can Ctr
- Study coordinator: Kreitchmann, Regis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.